Effect of Unblinding on Participants’ Perceptions of Risk and Confidence in a Large Double-blind Clinical Trial of Chemotherapy for Breast Cancer

類似資料

• Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
  著者:: Partridge, Ann H., 等
  出版事項: (2017)
• Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
  著者:: Ruddy, Kathryn J., 等
  出版事項: (2014)
• Survival Benefit Needed to Undergo Chemotherapy: Patients’ and Physicians’ Preferences: Patient and Physician Preferences instead of Patients’ and Physicians’ Preferences
  著者:: Vaz-Luis, Ines, 等
  出版事項: (2017)
• Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103)
  著者:: Miller, Kathy D., 等
  出版事項: (2018)
• Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
  著者:: Sparano, Joseph, 等
  出版事項: (2018)